![](/develop/static/imgs/pdf.png)
Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular carcinoma
{{custom_author.name}}, {{article.zuoZheEn}}
Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular carcinoma
[{{custom_ref.label}}] |
{{custom_citation.content}}
CrossRef
ADS
Pubmed
arXiv
Google scholar
|
/
〈 |
|
〉 |